Deliver a measure of success to your cardiac arrhythmia patients with the THERMOCOOL SMARTTOUCH® Catheter. Greater catheter stability results in more consistent contact force, producing more uniform lesions. The SMART-AF Trial evaluated the safety and effectiveness of the THERMOCOOL SMARTTOUCH® Catheter in patients with drug-resistant paroxysmal atrial fibrillation. One-year results from the trial showed patients experienced an overall success rate of 74 percent.1 Importantly, a subanalysis from the trial demonstrated an 88 percent success rate when contact force was within an investigator-selected range greater than or equal to 85 percent of time.
Features & Benefits
Provides consistent movement in response to contact force using precision spring
Sends accurate location reference signal via location sensor and transmitter coil
Promotes consistent lesion formation
Reduces ablation time2
Improves outcomes with more stable catheter-tissue contact force3
Force-sensing technology that provides real-time measurement of contact force between the catheter tip and the heart wall
Tip electrode serves to deliver RF current from the RF generator to the desired ablation site
A thermocouple temperature sensor is embedded in the tip electrode
High-torque shaft with a bi-directional deflectable tip section containing an array of electrodes